Drugs like Ozempic and Wegovy, containing semaglutide, are gaining popularity for their weight loss and health improvement benefits.
Semaglutide works like a natural hormone, making people feel fuller, slowing down digestion, and reducing food intake.
Clinical trials have shown that these drugs can reduce the risk of heart attacks, strokes, and even death.
However, these drugs are expensive, raising questions about whether health insurance programs like Medicaid should cover them.
Some experts think that these medications might actually save money in the long run because they can prevent other costly health problems caused by obesity.
Jason Abaluck, a health economist at Yale, led a study to determine whether semaglutide drugs help reduce overall health care costs.
Author's summary: Ozempic and Wegovy's cost-effectiveness is being studied to determine their value in healthcare.